These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21568748)

  • 1. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.
    Araszkiewicz A; Naskret D; Niedzwiecki P; Samborski P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Diabetes Technol Ther; 2011 Aug; 13(8):837-42. PubMed ID: 21568748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
    Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
    Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.
    Gerrits EG; Lutgers HL; Kleefstra N; Graaff R; Groenier KH; Smit AJ; Gans RO; Bilo HJ
    Diabetes Care; 2008 Mar; 31(3):517-21. PubMed ID: 18039805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between small fiber neuropathy and higher skin accumulation of advanced glycation end products in patients with type 1 diabetes.
    Araszkiewicz A; Gandecka A; Nowicki M; Uruska A; Malińska A; Kowalska K; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
    Pol Arch Med Wewn; 2016 Nov; 126(11):847-853. PubMed ID: 27906877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
    Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.
    Lutgers HL; Graaff R; Links TP; Ubink-Veltmaat LJ; Bilo HJ; Gans RO; Smit AJ
    Diabetes Care; 2006 Dec; 29(12):2654-9. PubMed ID: 17130200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.
    de Ranitz-Greven WL; Bos DC; Poucki WK; Visser GH; Beulens JW; Biesma DH; de Valk HW
    Diabetes Technol Ther; 2012 Jan; 14(1):43-9. PubMed ID: 21875328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence in type 2 diabetes: beyond blood glucose.
    Monami M; Lamanna C; Gori F; Bartalucci F; Marchionni N; Mannucci E
    Diabetes Res Clin Pract; 2008 Jan; 79(1):56-60. PubMed ID: 17707942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
    Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
    J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.
    Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
    Hartog JW; de Vries AP; Lutgers HL; Meerwaldt R; Huisman RM; van Son WJ; de Jong PE; Smit AJ
    Ann N Y Acad Sci; 2005 Jun; 1043():299-307. PubMed ID: 16037252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.